Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles’ Heel of Targeted Therapy

February 24th, 2015 by Christal D. Sohl, Molly R. Ryan, BeiBei Luo, Kathleen M. Frey and Karen S. Anderson

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.5b00014
  • Posted in ACS Chemical Biology, Publications
  • Comments Off on Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles’ Heel of Targeted Therapy